- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/4709 - Non-condensed quinolines containing further heterocyclic rings
Patent holdings for IPC class A61K 31/4709
Total number of patents in this class: 5143
10-year publication summary
368
|
384
|
401
|
368
|
444
|
436
|
410
|
416
|
330
|
96
|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Janssen Pharmaceutica N.V. | 3839 |
83 |
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 616 |
77 |
Bristol-myers Squibb Company | 5080 |
57 |
Boehringer Ingelheim International GmbH | 4629 |
55 |
F. Hoffmann-La Roche AG | 7958 |
53 |
Centre National de La Recherche Scientifique | 9632 |
53 |
Vertex Pharmaceuticals Incorporated | 1581 |
50 |
Arog Pharmaceuticals, Inc. | 49 |
45 |
The Regents of the University of California | 18943 |
43 |
Gilead Sciences, Inc. | 1879 |
43 |
Novartis AG | 11238 |
36 |
Merck Patent GmbH | 5909 |
36 |
Kura Oncology, Inc. | 105 |
36 |
Amgen Inc. | 3779 |
35 |
Institut Curie | 531 |
35 |
Taisho Pharmaceutical Co., Ltd. | 844 |
35 |
Abivax | 105 |
33 |
Forma Therapeutics, Inc. | 164 |
33 |
Universite de Montpellier | 920 |
32 |
Merck Sharp & Dohme LLC | 3689 |
32 |
Other owners | 4241 |